Health Technology Assessment: From Policy to Patient Access

The pathway from innovative digital health technology development to widespread patient access remains fraught with regulatory complexity and evaluation hurdles. While digital solutions promise transformative healthcare improvements, developers face intricate assessment frameworks that vary significantly across European healthcare systems. Successfully navigating Health Technology Assessment (HTA) processes requires strategic understanding of evidence requirements, value demonstration metrics, and regional policy variations.

This masterclass deep dives into the European HTA landscape such as the German DiGA framework and French PECAN pathway, offering practical insights for developers seeking to accelerate patient access while satisfying rigorous evaluation standards. By mastering these pathways, organizations can design more effective market entry strategies, align development with assessment criteria, and ultimately deliver technologies to patients more efficiently.

Join us to discuss:

• How do HTA requirements and evaluation frameworks differ across key European markets, and what core evidence elements remain consistent?
• What lessons can be drawn from successful and unsuccessful HTA submissions for digital health technologies in recent years?
• How can developers proactively incorporate HTA considerations into product development cycles to streamline eventual market access?
• What emerging trends in European health policy may impact future HTA processes for digital health innovations?